Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × spartalizumab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Solid Tumors 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

poly ICLC 1 pembrolizumab 1 atezolizumab 1 Specimen Handling 1 Sorafenib 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 DT2216 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡